Go Pro

Baxter International (BAX) Stock Forecast & Price Target

Baxter International logo
$26.66 -0.39 (-1.42%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$26.65 -0.02 (-0.06%)
As of 08/14/2026 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Baxter International - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
2
Hold
9
Buy
2

Based on 13 Wall Street analysts who have issued ratings for Baxter International in the last 12 months, the stock has a consensus rating of "Hold." Out of the 13 analysts, 2 have given a sell rating, 9 have given a hold rating, and 2 have given a buy rating for BAX.

Consensus Price Target

$22.45
-15.79% Downside
According to the 13 analysts' twelve-month price targets for Baxter International, the average price target is $22.45. The highest price target for BAX is $28.00, while the lowest price target for BAX is $15.00. The average price target represents a forecasted downside of -15.79% from the current price of $26.67.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for BAX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Baxter International and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BAX Analyst Ratings Over Time

TypeCurrent Forecast
8/15/25 to 8/15/26
1 Month Ago
7/16/25 to 7/16/26
3 Months Ago
5/17/25 to 5/17/26
1 Year Ago
8/15/24 to 8/15/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
Hold
9 Hold rating(s)
7 Hold rating(s)
8 Hold rating(s)
6 Hold rating(s)
Sell
2 Sell rating(s)
4 Sell rating(s)
3 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$22.45$19.91$19.91$30.11
Forecasted Upside-15.79% Downside-14.77% Downside15.11% Upside24.43% Upside
Consensus RatingHoldReduceReduceHold

BAX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BAX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Baxter International Stock vs. The Competition

TypeBaxter InternationalHealthcare CompaniesBroader Market
Consensus Rating Score
2.00
2.30
2.53
Consensus RatingHoldHoldModerate Buy
Predicted Upside-15.79% Downside785.24% Upside11.05% Upside
News Sentiment Rating
Positive News

See Recent BAX News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
8/11/2026
Zacks Research logo
Zacks Research
5 of 5 stars
 UpgradeStrong SellHold
7/31/2026
Weiss Ratings logo
Weiss Ratings
5 of 5 stars
 UpgradeSell (D-)Sell (D)
7/31/2026
Larry Biegelsen
1 of 5 stars
Boost TargetEqual Weight$19.00 ➝ $23.00-12.59%
7/31/2026UpgradeSellNeutral$17.00 ➝ $28.00+5.06%
7/28/2026Boost TargetNeutralHold$19.00 ➝ $25.00+2.64%
7/28/2026Boost TargetHold$19.00 ➝ $24.00-1.71%
7/27/2026Boost TargetHold$20.00 ➝ $24.00+2.98%
7/15/2026Boost TargetNeutral$19.00 ➝ $21.00-6.11%
5/1/2026Boost TargetOverweight$25.00 ➝ $27.00+56.48%
4/6/2026 Lower TargetOutperform$23.00 ➝ $22.00+32.09%
2/13/2026 Lower TargetHold$21.00 ➝ $19.00+1.04%
12/2/2025Lower TargetUnderweight$19.00 ➝ $15.00-20.83%
10/31/2025 Lower Target$25.00 ➝ $19.00+2.90%
10/31/2025DowngradeBuyHold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 03:19 PM ET.


Should I Buy Baxter International Stock? BAX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, August 14, 2026. Please send any questions or comments about these Baxter International pros and cons to contact@marketbeat.com.

Baxter International
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Baxter International Inc.:

  • The current stock price is around $22, which is considered attractive given the company's potential for growth in the healthcare sector.
  • Baxter International Inc. reported a positive return on equity of 16.15%, indicating effective management and profitability relative to shareholder equity.
  • The company has shown revenue growth, with a recent increase of 5.3% compared to the same quarter last year, suggesting strong demand for its medical products.
  • Analysts forecast an earnings per share (EPS) of 1.91 for the current year, which reflects optimism about the company's financial performance.
  • With a market capitalization of approximately $12.60 billion, Baxter International Inc. is positioned as a significant player in the healthcare market, attracting institutional investors who own over 90% of its stock.

Baxter International
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Baxter International Inc. for these reasons:

  • The company has a negative net margin of 9.70%, which indicates that it is currently spending more than it earns, raising concerns about profitability.
  • Baxter International Inc. has a debt-to-equity ratio of 1.43, suggesting that it relies significantly on debt financing, which can be risky in volatile markets.
  • Recent analyst ratings show a consensus rating of "Reduce," indicating that many analysts are cautious about the stock's future performance.
  • Despite revenue growth, the earnings per share decreased from $0.59 in the previous year to $0.36 recently, which may signal challenges in maintaining profitability.
  • Some analysts have set target prices below the current stock price, indicating potential downside risk for investors considering entry points.

BAX Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Baxter International is $22.45, with a high forecast of $28.00 and a low forecast of $15.00.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last twelve months. There are currently 2 sell ratings, 9 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" BAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAX, but not buy additional shares or sell existing shares.

According to analysts, Baxter International's stock has a predicted downside of -15.79% based on their 12-month stock forecasts.

Over the previous 90 days, Baxter International's stock had 5 upgrades and 2 downgrades by analysts.

Baxter International has been rated by research analysts at Citigroup, Stifel Nicolaus, TD Cowen, The Goldman Sachs Group, UBS Group, Weiss Ratings, Wells Fargo & Company, and Zacks Research in the past 90 days.

Analysts like Baxter International less than other "healthcare" companies. The consensus rating score for Baxter International is 2.00 while the average consensus rating score for "healthcare" companies is 2.30. Learn more on how BAX compares to other companies.


This page (NYSE:BAX) was last updated on 8/15/2026 by MarketBeat.com Staff.
From Our Partners